August 6, 2021
Patient Choice Will Drive Adoption of Decentralized Clinical Trials
Written by: Amy Ripston
August 6, 2021
The Association of Clinical Research Professionals
Dave Kelleher, CEO of 4G Clinical, speaks with ACRP about how patient choice will determine the future adoption of decentralized clinical trials.
The clinical trial industry is clearly warming to the ideas behind decentralized clinical trials (DCTs), but it is ultimately patients who will drive the rate of adoption, says Dave Kelleher, CEO of 4G Clinical, a randomization and trial supply management company.
“People like choices, but if patients don’t accept” remote trials, DCTs may not continue to grow in popularity, Kelleher says. In any event, he notes, “Sites are never going away. Clinicians are not going away.”
Read the full article from the Association of Clinical Research Professionals.
Tag(s):
News
Related Blog Posts Headline
View All Blog Posts
January 3, 2022
The Benefits of Hybrid DtP Supply Chain Models for Patient Drug Access
Read More
November 24, 2021
The Need for Adaptive Trial Design in Oncology Studies
Read More
May 6, 2020